Miguel Martín

Researcher Next ID · RN-002999

Researcher · Medicine

Madrid, Spain

Not currently recruitingFunding unknown

Research interests

Medicine

Biochemistry, Genetics and Molecular Biology

Advanced Breast Cancer Therapies

Breast Cancer Treatment Studies

Cancer Treatment and Pharmacology

HER2/EGFR in Cancer Research

Cancer Genomics and Diagnostics

Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2−, Node-Positive, High-Risk, Early Breast Cancer (monarchE)
Journal of Clinical Oncology · 2020 · https://doi.org/10.1200/jco.20.02514
Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: MONALEESA-3
Journal of Clinical Oncology · 2018 · https://doi.org/10.1200/jco.2018.78.9909
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
The Lancet Oncology · 2017 · https://doi.org/10.1016/s1470-2045(17)30777-5
Palbociclib and Letrozole in Advanced Breast Cancer
New England Journal of Medicine · 2016 · https://doi.org/10.1056/nejmoa1607303
Adjuvant Trastuzumab in HER2-Positive Breast Cancer
New England Journal of Medicine · 2011 · https://doi.org/10.1056/nejmoa0910383

No projects listed.